Evaluate the Safety and Performance of the AccuCinch® Ventricular Repair System - The CorCinch-EU Study

Recruiting at24 trial locations

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Ancora Heart, Inc.

No Placebo Group

Trial Summary

What is the purpose of this trial?

This is prospective, non-randomized, single-arm, international, multicenter, clinical safety and performance clinical investigation to evaluate the AccuCinch® Ventricular Repair System for the treatment of heart failure, with or without functional mitral regurgitation due to dilated ischemic or non-ischemic cardiomyopathy

Research Team

Michael Zapien, MS, CCRA

Principal Investigator

Ancora Heart, Inc.

Eligibility Criteria

Inclusion Criteria

Age ≥ 18 years

Subjects who present with heart failure with or without functional mitral regurgitation due to dilated cardiomyopathy of ischemic or non-ischemic etiology

For subjects with FMR, severity of FMR: ≥ Moderate 2+

Treatment Details

Interventions

• AccuCinch® Ventricular Repair System (Procedure)

Who Is Running the Clinical Trial?

Ancora Heart, Inc.

Lead Sponsor

Trials

9

Recruited

620+